ESSA Pharma EPIX

$ 1.6 0.0%

Annual report 2024
added 12-17-2024

ESSA Pharma Financial Statements 2011-2024 | EPIX

Annual Financial Statements ESSA Pharma

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	73.5 M	231 M	141 M	308 M	137 M	40.1 M	13.9 M	8.06 M	59.2 M	110 M	-	-	-	-
Shares	44.3 M	44.1 M	44 M	38.5 M	22.4 M	8.43 M	4.57 M	1.45 M	1.35 M	918 K	-	-	-	-
Historical Prices	1.66	5.24	3.2	8.17	27.1	4.8	3.62	3.66	44.2	49.6	-	-	-	-
Net Income	-28.5 M	-26.6 M	-35.1 M	-36.8 M	-23.4 M	-10.4 M	-11.6 M	-4.72 M	-13.1 M	-8.57 M	-1.82 M	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-22.8 M	-12.2 M	-10.8 M	-10.8 M	-18.6 M	-9.2 M	-1.71 M	-	-	-
Operating Expenses	34.4 M	32.1 M	37 M	37.2 M	23.5 M	12.2 M	10.8 M	10.9 M	18.7 M	9.23 M	-	-	-	-
General and Administrative Expenses	13.2 M	10.8 M	12.5 M	12.9 M	11.3 M	5.46 M	5.89 M	5.09 M	5.58 M	3.7 M	1.04 M	-	-	-

All numbers in USD currency

Quarterly Income Statement ESSA Pharma

	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	44.4 M	44.2 M	44.1 M	44.1 M	44.1 M	44.1 M	44.1 M	44.1 M	44.1 M	44 M	44 M	44 M	34.9 M	36.5 M	33.3 M	20.8 M	20.8 M	33.3 M	20.8 M	20.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-7.23 M	-8.99 M	-5.96 M	-	-7.3 M	-7.06 M	-6.74 M	-	-8.83 M	-10.9 M	-9.1 M	-	-8.75 M	-13 M	-6.53 M	-6.53 M	-6.53 M	-6.53 M	-4.61 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	8.64 M	10.5 M	7.59 M	-	8.91 M	8.21 M	7.87 M	-	9.29 M	11.5 M	9.09 M	-	9.37 M	11.9 M	6.7 M	19.6 M	5.07 M	6.7 M	4.94 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	3.17 M	4.32 M	2.22 M	-	2.64 M	3.73 M	2.52 M	-	2.9 M	3.82 M	3.06 M	-	3.12 M	4.62 M	2.21 M	9.17 M	2.17 M	2.21 M	2.14 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency